Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gastric cancer: an infectious disease.

Literature DB >> 20937454

Gastric cancer: an infectious disease.

M Blanca Piazuelo¹, Meira Epplein, Pelayo Correa.

Abstract

The role of infectious agents and chronic inflammation in carcinogenesis is being increasingly recognized. It has been estimated that about 18% of cancers are directly linked to infections, particularly gastric adenocarcinoma (Helicobacter pylori), cervical carcinoma (human papilloma viruses), and hepatocarcinoma (hepatitis B and C viruses). Multiple clinical trials of COX-2 inhibitors and other antiinflammatory agents have shown a beneficial effect on the development of diverse tumors, such as those of the colon, stomach, prostate, and breast. However, their mechanism of action is not completely understood and may differ among the infectious agents and tumor types. Because gastric adenocarcinomas account for more than 90% of all gastric malignancies, this review focuses on adenocarcinomas.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2010 PMID： 20937454 PMCID： PMC2954127 DOI： 10.1016/j.idc.2010.07.010

Source DB: PubMed Journal: Infect Dis Clin North Am ISSN： 0891-5520 Impact factor: 5.982

100 in total

1. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.

Authors: E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal: Nature Date: 2001-07-05 Impact factor: 49.962

Review 2. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer.

Authors: N Yamaguchi; T Kakizoe
Journal: Lancet Oncol Date: 2001-02 Impact factor: 41.316

3. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.

Authors: J G Fox; P Beck; C A Dangler; M T Whary; T C Wang; H N Shi; C Nagler-Anderson
Journal: Nat Med Date: 2000-05 Impact factor: 53.440

4. Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma?

Authors: Luis E Bravo; Leen-Jan van Doom; J Luis Realpe; Pelayo Correa
Journal: Am J Gastroenterol Date: 2002-11 Impact factor: 10.864

5. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Authors: Carlos A González; Guillem Pera; Antonio Agudo; H Bas Bueno-de-Mesquita; Marco Ceroti; Heiner Boeing; Mandy Schulz; Giuseppe Del Giudice; Mario Plebani; Fátima Carneiro; Franco Berrino; Carlotta Sacerdote; Rosario Tumino; Salvatore Panico; Göran Berglund; Henrik Simán; Göran Hallmans; Roger Stenling; Carmen Martinez; Miren Dorronsoro; Aurelio Barricarte; Carmen Navarro; José R Quiros; Naomi Allen; Timothy J Key; Sheila Bingham; Nicholas E Day; Jakob Linseisen; Gabriele Nagel; Kim Overvad; Majken K Jensen; Anja Olsen; Anne Tjønneland; Frederike L Büchner; Petra H M Peeters; Mattijs E Numans; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Dimitrios Roukos; Antonia Trichopoulou; Theodora Psaltopoulou; Eiliv Lund; Corinne Casagrande; Nadia Slimani; Mazda Jenab; Elio Riboli
Journal: Int J Cancer Date: 2006-05-15 Impact factor: 7.396

Review 6. Helicobacter pylori VacA, a paradigm for toxin multifunctionality.

Authors: Timothy L Cover; Steven R Blanke
Journal: Nat Rev Microbiol Date: 2005-04 Impact factor: 60.633

Review 7. Aspirin and NSAIDs for the prevention of colorectal cancer.

Authors: John A Baron
Journal: Recent Results Cancer Res Date: 2009

Review 8. Helicobacter pylori and gastric carcinogenesis.

Authors: Masanori Hatakeyama
Journal: J Gastroenterol Date: 2009-03-07 Impact factor: 7.527

9. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.

Authors: Henry T Lynch; Pardeep Kaurah; Debrah Wirtzfeld; Wendy S Rubinstein; Scott Weissman; Jane F Lynch; William Grady; Sara Wiyrick; Janine Senz; David G Huntsman
Journal: Cancer Date: 2008-06-15 Impact factor: 6.860

10. The global burden of cancer: priorities for prevention.

Authors: Michael J Thun; John Oliver DeLancey; Melissa M Center; Ahmedin Jemal; Elizabeth M Ward
Journal: Carcinogenesis Date: 2009-11-24 Impact factor: 4.944

36 in total

1. Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians.

Authors: Courtney Ek; Mark T Whary; Melanie Ihrig; Luis E Bravo; Pelayo Correa; James G Fox
Journal: Helicobacter Date: 2012-04 Impact factor: 5.753

2. Inhibition of 15-hydroxyprostaglandin dehydrogenase by Helicobacter pylori in human gastric carcinogenesis.

Authors: Yeon-Mi Ryu; Seung-Jae Myung; Young Soo Park; Dong-Hoon Yang; Ho June Song; Jin-Yong Jeong; Sun Mi Lee; Miyeoun Song; Do Hoon Kim; Hyo-Jeong Lee; Soo-Kyung Park; Stephen P Fink; Sandy D Markowitz; Kee Wook Jung; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Hwoon-Yong Jung; Suk-Kyun Yang; Jin-Ho Kim
Journal: Cancer Prev Res (Phila) Date: 2013-02-19

10. Canine Gastric Carcinomas: A Histopathological and Immunohistochemical Study and Similarities with the Human Counterpart.

Authors: Alexandros Hardas; Alejandro Suárez-Bonnet; Sam Beck; William E Becker; Gustavo A Ramírez; Simon L Priestnall
Journal: Animals (Basel) Date: 2021-05-14 Impact factor: 2.752

Gastric cancer: an infectious disease.

1. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.

Review 2. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer.

3. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.

4. Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma?

5. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Review 6. Helicobacter pylori VacA, a paradigm for toxin multifunctionality.

Review 7. Aspirin and NSAIDs for the prevention of colorectal cancer.

Review 8. Helicobacter pylori and gastric carcinogenesis.

9. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.

10. The global burden of cancer: priorities for prevention.

1. Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians.

2. Inhibition of 15-hydroxyprostaglandin dehydrogenase by Helicobacter pylori in human gastric carcinogenesis.

Review 3. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Review 4. The prevention of infection-associated cancers.

5. Cancer vaccines.

6. Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori.

7. MicroRNAs in hereditary diffuse gastric cancer.

8. How cancer shapes evolution, and how evolution shapes cancer.

9. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.

10. Canine Gastric Carcinomas: A Histopathological and Immunohistochemical Study and Similarities with the Human Counterpart.